Kazuhiko Shien

Title: Kazuhiko Shien: Innovator in Cancer Research

Introduction

Kazuhiko Shien is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies that target specific proteins involved in cancer metastasis.

Latest Patents

Kazuhiko Shien holds a patent for an "Anti-S100A8/A9 antibody and use thereof." This invention provides a substance capable of effectively suppressing cancer metastasis or a pharmaceutical composition that acts on inflammatory diseases. The composition contains an antibody or an antibody fragment that has antigen-binding activity for the S100A8/A9 heterodimer. This invention blocks the interaction between S100A8/A9 and its receptors, thereby strongly suppressing cancer metastasis both in vitro and in vivo, or alleviating inflammation. The anti-S100A8/A9 antibody can significantly impact cancer treatment and inflammatory conditions.

Career Highlights

Kazuhiko Shien has worked at notable institutions, including Okayama University and Niigata University. His research has focused on developing therapeutic strategies to combat cancer and inflammatory diseases, showcasing his dedication to advancing medical science.

Collaborations

Some of his notable coworkers include Masakiyo Sakaguchi and Shinichi Toyooka. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.

Conclusion

Kazuhiko Shien's work in developing the anti-S100A8/A9 antibody represents a significant advancement in cancer research. His contributions have the potential to improve treatment options for patients facing cancer and inflammatory diseases.